Dr. Jia Cheng
Overview
Jia Cheng is a Neurologist in Freehold, New Jersey. Dr. Cheng is rated as an Experienced provider by MediFind in the treatment of Conversion Disorder. Her top areas of expertise are Stroke, Parkinson's Disease, Movement Disorders, and Generalized Tonic-Clonic Seizure. Dr. Cheng is currently accepting new patients.
Her clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
901 West Main Street, Ambulatory Campus Building B Suite 120, Freehold, NJ 07728
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Deepika Bajaj is a Neurologist in Elmhurst, New York. Dr. Bajaj is rated as an Advanced provider by MediFind in the treatment of Conversion Disorder. Her top areas of expertise are Conversion Disorder, Cerebellar Degeneration, Vertigo, and Hemiplegia.
Gramercy Park Physicians LLP
Daniel Macgowan is a Neurologist in New York, New York. Dr. Macgowan is rated as a Distinguished provider by MediFind in the treatment of Conversion Disorder. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3.
Guoping Zhou is a Neurologist in Flushing, New York. Dr. Zhou is rated as an Advanced provider by MediFind in the treatment of Conversion Disorder. His top areas of expertise are Conversion Disorder, Peripheral Neuropathy, Vertigo, and Seizures.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Generalized Tonic-Clonic Seizure
- Movement DisordersDr. Cheng isAdvanced. Learn about Movement Disorders.
- Parkinson's DiseaseDr. Cheng isAdvanced. Learn about Parkinson's Disease.
- SeizuresDr. Cheng isAdvanced. Learn about Seizures.
- StrokeDr. Cheng isAdvanced. Learn about Stroke.
- Transient Global AmnesiaDr. Cheng isAdvanced. Learn about Transient Global Amnesia.
- Experienced
- Alzheimer's DiseaseDr. Cheng isExperienced. Learn about Alzheimer's Disease.
- ApoplexyDr. Cheng isExperienced. Learn about Apoplexy.
- ArachnoiditisDr. Cheng isExperienced. Learn about Arachnoiditis.
- Bell's PalsyDr. Cheng isExperienced. Learn about Bell's Palsy.
- Benign Rolandic EpilepsyDr. Cheng isExperienced. Learn about Benign Rolandic Epilepsy.
- Brain Stem CancerDr. Cheng isExperienced. Learn about Brain Stem Cancer.